12:00 AM
Sep 18, 2014
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Acute lymphoblastic leukemia (ALL) Lysine-specific demethylase 6A (KDM6A; UTX); KDM6B (JMJD3) Cell culture...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >